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Introduction 
According to the K i e l classification, 
Burkitt 's lymphoma ( B L ) is a high-grade 
malignant non-Hodgkin 's lymphoma of 
the B-cell lineage. In all the B L cells one 
finds a gene translocation which can acti-
vate the c-rnyc oncogen. In addition, 
95% of the endemic-type B L s are infect-
ed with the Epstein-Barr virus ( E B V ) . In 
vitro infection with E B V can transform 
peripheral b lood B-cells into immortal-
ized nonmalignant lymphoblastoid cell 
lines ( L C L s ) . L C L s can also grow out 
spontaneously from peripheral b lood 
lymphocytes of EBV-posi t ive donors af-
ter the removal of T cells or their inhibi-
tion by cyclosporin A in vitro. In vivo 
EBV-infected cells are normally con-
trolled by the immune system. Immuno-
suppression leads to a higher risk of 
EBV-associated oligoclonal lymphoma. 
In vitro cytotoxic chromium release as-
says performed with pairs o f B L cells and 
L C L s of the same B L patient have shown 
that B L s are not recognized by cytotoxic 
T cells ( C T L s ) in contrast to L C L s [1]. 
Mos t of the EBV-specif ic C T L s are H L A 
class I restricted; there are, however, up 
to 30% of class II restricted C T L s in the 
E B V system. One possibility for the B L 
cells not being recognized is the altered 
surface expression of EBV-specif ic struc-
tures which have been functionally 
termed lymphocyte-detected membrane 
antigen ( L Y D M A ) . One of the possible 
candidates for L Y D M A is the latent 
membrane protein L M P of the reading 
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frame B N L F 1 , which has been shown to 
be differentially expressed on B L cells 
and L C L s [2]. The specific recognition 
may also be influenced by an altered 
H L A class I or class II expression as sug-
gested by Torsteindottir et al . [3]. We 
therefore studied the H L A expression on 
eight pairs of B L cells and L C L s . 
Results 
F o r measuring the H L A density we used 
a radioimmunoassay with monoclonal 
antibodies against a framework determi-
nant of class I (clone W6/32) or class II 
(clone L243) antigen and 1 2 5 I - l abe led 
protein A . To correct for differences in 
surface area, cells were also incubated 
with saturating amounts of a mixture of 
polyclonal antisera against B L cells and 
L C L s ; the cpm values obtained with the 
monoclonal antibodies were divided by 
the cpm values of the polyclonal serum 
mixture, leading to values of relative den-
sity of class I and II antigen. M o s t of the 
pairs tested showed a significantly lower 
H L A class I (Fig . 1) and class II density 
(data not shown) on the B L cells. E B V -
positive L C L s showed a much higher 
H L A density than peripheral blood B -
cells of the same donor (data not shown). 
In contrast to the corresponding L C L s , 
both i n EBV-posi t ive and -negative B L 
cells the H L A expression could be stimu-
lated by a factor 3 - 5 by I F N - y (Fig. 2) 
and T N F (data not shown). T N F did not 
show a direct toxic effect against B L cells 
or L C L s (data not shown). 
After immunoprecipitation we per-
formed a biochemical separation o f H L A 
class I and II antigens by one-dimension-
al S D S - P A G E and two-dimensional elec-
trophoresis which separates according 
to the isoelectric point and molecular 
weight. B L cells and L C L s of the same 
patient showed a different pattern: some 
of the H L A specificities expressed on 
L C L s were not found - or some only in 
traces - on the corresponding B L cells 
(Fig. 3). After incubation with tu-
nicamycin preventing glycosylation of 
proteins, these differences were still de-
tected, indicating that they are not due to 
differences in glycosylation in B L cells 
and L C L s (data not shown). These dif-
ferences could not be affected by I F N - y 
or T N F (data not shown). E B V infection 
itself d id not alter H L A expression qual-
itatively. This was shown by a compari-
son of EBV-negative pokeweed mitogen-
stimulated B-blasts and corresponding 
EBV-pos i t ive L C L s and a comparison of 
an EBV-negative B L - c e l l line before and 
after infection with E B V (data not 
shown). 
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Fig. 3. SDS P A G E 
and two-dimen-
sional gel elec-
trophoresis of H L A 
class I immunopre-
cipitates of five B L / 
L C L pairs 
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Summary and Conclusions 
Our data show that 
- M o s t B L cells express significantly less 
H L A class I and II than the corre-
sponding L C L s . 
- Lymphoblastoid cell lines have a much 
higher H L A class I and II density than 
normal peripheral blood B cells. 
There are qualitative differences in 
class I and II expression in most B L / 
L C L pairs. 
These qualitative differences are not 
caused by E B V infection. They might 
be due to a selective downregulation of 
H L A specifities by c-rnyc activation. 
We conclude that these modifications o f 
H L A expression may well play a role in 
the reduced specific immune recognition 
of Burkitt 's lymphoma cells. 
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